A team of researchers has identified a way to prevent symptom onset, weight loss and paralysis, and extend survival in a mouse model of amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), providing a new avenue of research for the development of therapeutics for ALS and other motor neuron diseases.